{"gene":"PCGF3","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2017,"finding":"PCGF3/5-PRC1 complex initiates Polycomb recruitment during X chromosome inactivation by catalyzing H2AK119 ubiquitylation chromosome-wide, which signals recruitment of other noncanonical PRC1 complexes and PRC2, the latter leading to H3K27 methylation. Pcgf3/5 double knockout results in female-specific embryo lethality and abrogates Xist-mediated gene repression.","method":"Genetic knockout (Pcgf3/5 double KO), ChIP-seq, RNA-seq, functional gene silencing assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic epistasis, ChIP-seq, and functional silencing assays across multiple orthogonal methods, replicated in a companion paper","pmids":["28596365"],"is_preprint":false},{"year":2017,"finding":"The RNA-binding protein hnRNPK binds the Xist RNA Polycomb Interaction Domain (XR-PID, a ~600 nt sequence encompassing the B-repeat element) and is the principal factor required to recruit PCGF3/5-PRC1 to the inactive X chromosome. Deletion of XR-PID abolishes Polycomb recruitment, gene silencing, and chromatin inaccessibility; synthetic tethering of hnRNPK to Xist RNA lacking XR-PID is sufficient to restore Polycomb recruitment.","method":"RNA pulldown, CLIP, deletion mapping of Xist RNA, synthetic tethering of hnRNPK, ATAC-seq, ChIP-seq","journal":"Molecular Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (pulldown, deletion, synthetic tethering, ChIP-seq, ATAC-seq) in a single rigorous study, consistent with companion Science paper","pmids":["29220657"],"is_preprint":false},{"year":2018,"finding":"TRF2 (telomere repeat binding factor 2) binds the PCGF3 promoter in a G-quadruplex motif-dependent manner, and this binding requires both the N-terminal and C-terminal domains of TRF2 to mediate PCGF3 promoter activity.","method":"G-quadruplex binding assays, promoter-reporter (luciferase) assays, TRF2 domain deletion constructs, chromatin immunoprecipitation","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — promoter-reporter and binding assays in a single lab with two orthogonal methods, but no in vivo functional consequence firmly established","pmids":["29589913"],"is_preprint":false},{"year":2021,"finding":"USF1 transcription factor binds the PCGF3 locus and increases its transcription. miR-210-3p targets USF1 and inhibits its expression, thereby reducing PCGF3 levels; PCGF3 knockdown mimics the effects of miR-210-3p overexpression on lung cancer cell proliferation, migration, and invasion in vitro and in vivo.","method":"Dual-luciferase reporter assay, RNA immunoprecipitation, siRNA knockdown, xenograft mouse model","journal":"OncoTargets and therapy","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — dual-luciferase reporter and RIP provide direct binding evidence; knockdown phenotype confirmed in vivo, but single lab","pmids":["34140779"],"is_preprint":false},{"year":2021,"finding":"PCGF3 promotes non-small cell lung cancer cell proliferation and migration by regulating CyclinB1, CyclinD1, and CDK4 expression (proliferation) and RhoA, RhoC, and CDC42 (migration), and these effects are mediated through the PI3K/AKT pathway, as demonstrated by pharmacological inhibition with LY294002.","method":"siRNA knockdown, Western blot, cell proliferation and migration assays, PI3K inhibitor (LY294002) rescue experiment","journal":"Experimental cell research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, downstream pathway placement based on pharmacological inhibition without direct biochemical linkage to PCGF3","pmids":["33485844"],"is_preprint":false},{"year":2024,"finding":"Nuclear PCGF3 negatively regulates antiviral immunity by suppressing interferon-stimulated gene (ISG) expression. Upon IFN-I stimulation, PCGF3 is recruited to interferon-stimulated response elements (ISREs) at ISG promoters, where it precludes STAT1 binding and diminishes ISRE activity. PCGF3 deficiency in innate immune cells augments ISG expression.","method":"PCGF3 knockdown/knockout in innate immune cells, ChIP assay at ISRE regions, STAT1 binding assays, reporter assays for ISRE activity","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and STAT1 competition assays provide direct mechanistic evidence in a single lab with orthogonal methods","pmids":["39368978"],"is_preprint":false},{"year":2024,"finding":"miR-106b-3p directly targets PCGF3 (validated by dual-luciferase reporter), and PCGF3 knockdown suppresses migration and invasion of HBV-infected HCC cells by reducing p-AKT/AKT and p-PI3K/PI3K signaling.","method":"Dual-luciferase reporter assay, siRNA knockdown, Western blot for PI3K/AKT pathway components, scratch/transwell migration assays","journal":"Frontiers in Cellular and Infection Microbiology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, direct targeting confirmed by luciferase but PI3K/AKT pathway link is based on downstream protein expression only","pmids":["39529637"],"is_preprint":false},{"year":2024,"finding":"In developing mouse neocortex neural stem cells, deletion of Pcgf3/5 (non-canonical PRC1) plays only a minor role in NSC proliferation and differentiation compared to canonical PRC1 (Pcgf2/4 deletion), which strongly reduces proliferation and alters lineage fate.","method":"Conditional knockout of Pcgf3/5 vs Pcgf2/4 in neural stem cells, proliferation and differentiation assays, ChIP-seq","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 2 / Weak — genetic KO with phenotypic readout and ChIP-seq but preprint, single lab, and the main finding for PCGF3/5 is a minor/negative result","pmids":["bio_10.1101_2024.08.07.606990"],"is_preprint":true}],"current_model":"PCGF3 is a subunit of the noncanonical PCGF3/5-PRC1 complex that initiates Polycomb-mediated X chromosome inactivation by catalyzing H2AK119 ubiquitylation chromosome-wide—a process triggered by hnRNPK binding to the Xist RNA B-repeat/XR-PID element—thereby recruiting other PRC1 complexes and PRC2 to establish H3K27 methylation and gene silencing; additionally, PCGF3 functions in innate immunity by being recruited to ISRE elements to block STAT1 binding and suppress interferon-stimulated gene expression, and its transcription is regulated by TRF2 via a G-quadruplex motif at its promoter and by USF1 downstream of miR-210-3p."},"narrative":{"mechanistic_narrative":"PCGF3 is a subunit of a noncanonical PRC1 complex (PCGF3/5-PRC1) that initiates Polycomb-mediated chromatin silencing, most clearly defined during X chromosome inactivation, where it catalyzes chromosome-wide H2AK119 ubiquitylation that in turn signals recruitment of other noncanonical PRC1 complexes and PRC2 to deposit H3K27 methylation [PMID:28596365]. Recruitment of PCGF3/5-PRC1 to the inactive X is directed by the RNA-binding protein hnRNPK, which binds the Xist RNA Polycomb Interaction Domain (XR-PID/B-repeat); deleting this element abolishes Polycomb recruitment and silencing, while synthetic tethering of hnRNPK restores it [PMID:29220657]. Loss of Pcgf3/5 causes female-specific embryonic lethality and abrogates Xist-mediated repression [PMID:28596365]. Beyond this developmental role, nuclear PCGF3 acts in innate immunity as a negative regulator of antiviral responses: upon type I interferon stimulation it is recruited to interferon-stimulated response elements where it precludes STAT1 binding and dampens interferon-stimulated gene expression [PMID:39368978]. PCGF3 transcription is controlled at its promoter by TRF2 acting through a G-quadruplex motif [PMID:29589913] and by USF1, whose activity is constrained by miR-210-3p [PMID:34140779].","teleology":[{"year":2017,"claim":"Established that PCGF3 is a functional initiator of Polycomb silencing rather than a passive complex member, by showing PCGF3/5-PRC1 deposits the H2AK119ub mark that nucleates downstream PRC1/PRC2 recruitment during X inactivation.","evidence":"Pcgf3/5 double knockout with ChIP-seq, RNA-seq, and functional silencing assays in mouse embryos","pmids":["28596365"],"confidence":"High","gaps":["Does not define the catalytic contribution of PCGF3 versus PCGF5 individually","Structure of the PCGF3/5-PRC1 complex and its catalytic mechanism not resolved","Generality of this initiator role beyond X inactivation not established here"]},{"year":2017,"claim":"Resolved how PCGF3/5-PRC1 is targeted to chromatin, identifying hnRNPK bound to the Xist XR-PID/B-repeat as the principal recruitment factor and showing tethering of hnRNPK is sufficient to drive Polycomb recruitment.","evidence":"RNA pulldown, CLIP, Xist deletion mapping, synthetic hnRNPK tethering, ATAC-seq and ChIP-seq","pmids":["29220657"],"confidence":"High","gaps":["Direct physical contact between hnRNPK and PCGF3 not biochemically mapped","Whether hnRNPK recruits PCGF3/5-PRC1 at non-Xist loci is unknown"]},{"year":2018,"claim":"Addressed how PCGF3 expression is set transcriptionally, showing TRF2 binds the PCGF3 promoter via a G-quadruplex motif and requires both its N- and C-terminal domains to drive promoter activity.","evidence":"G-quadruplex binding assays, luciferase promoter-reporter assays, TRF2 domain-deletion constructs, ChIP","pmids":["29589913"],"confidence":"Medium","gaps":["No in vivo functional consequence of TRF2-driven PCGF3 expression established","Connection to PCGF3's Polycomb or immune functions not made"]},{"year":2021,"claim":"Placed PCGF3 in a cancer-relevant regulatory axis, showing USF1 activates PCGF3 transcription and that miR-210-3p represses USF1 to lower PCGF3, with PCGF3 knockdown phenocopying tumor-suppressive effects in lung cancer.","evidence":"Dual-luciferase reporter, RNA immunoprecipitation, siRNA knockdown, xenograft model","pmids":["34140779"],"confidence":"Medium","gaps":["Mechanism by which PCGF3 promotes tumor phenotypes not biochemically defined here","Single-lab study"]},{"year":2021,"claim":"Proposed a downstream effector pathway for PCGF3 in lung cancer, linking it to cell-cycle and motility regulators via PI3K/AKT signaling.","evidence":"siRNA knockdown, Western blot of cyclins/Rho GTPases, migration assays, LY294002 PI3K inhibition","pmids":["33485844"],"confidence":"Low","gaps":["Pathway placement rests on pharmacological inhibition without direct biochemical link to PCGF3","No demonstration that PCGF3 acts via its Polycomb chromatin function here"]},{"year":2024,"claim":"Defined a chromatin-independent-from-XCI role for nuclear PCGF3 in innate immunity, showing it is recruited to ISRE elements where it blocks STAT1 binding to suppress interferon-stimulated genes.","evidence":"PCGF3 knockdown/knockout in innate immune cells, ChIP at ISREs, STAT1 binding and ISRE reporter assays","pmids":["39368978"],"confidence":"Medium","gaps":["Whether ISRE recruitment requires the PCGF3/5-PRC1 complex or H2AK119ub is unknown","Mechanism of PCGF3 recruitment to ISREs not defined","Single-lab study"]},{"year":2024,"claim":"Extended the cancer-axis model to HBV-associated HCC, identifying miR-106b-3p as a direct repressor of PCGF3 with knockdown reducing migration/invasion via PI3K/AKT readouts.","evidence":"Dual-luciferase reporter, siRNA knockdown, Western blot for PI3K/AKT, migration/invasion assays","pmids":["39529637"],"confidence":"Low","gaps":["PI3K/AKT link based only on downstream protein expression, not direct biochemistry","Single-lab study"]},{"year":2024,"claim":"Tested the developmental breadth of PCGF3/5-PRC1, finding it contributes only minimally to neural stem cell proliferation and fate compared with canonical PCGF2/4-PRC1.","evidence":"Conditional Pcgf3/5 vs Pcgf2/4 knockout in mouse neocortex NSCs, proliferation/differentiation assays, ChIP-seq (preprint)","pmids":["bio_10.1101_2024.08.07.606990"],"confidence":"Low","gaps":["Preprint, single lab, and a largely negative result for PCGF3/5","Does not establish whether noncanonical PRC1 has context-specific roles elsewhere in development"]},{"year":null,"claim":"How PCGF3's two documented activities—Polycomb H2AK119ub deposition and ISRE-based STAT1 competition—are mechanistically related, and whether its tumor phenotypes derive from either, remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No unified model linking chromatin silencing and interferon suppression","No structural characterization of PCGF3 within its complex","Direct substrates and recruitment determinants outside Xist not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[5]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,5]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[5]}],"complexes":["PCGF3/5-PRC1"],"partners":["PCGF5","HNRNPK","STAT1","TRF2","USF1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q3KNV8","full_name":"Polycomb group RING finger protein 3","aliases":["RING finger protein 3A"],"length_aa":242,"mass_kda":28.1,"function":"Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. Within the PRC1-like complex, regulates RNF2 ubiquitin ligase activity (PubMed:26151332). Plays a redundant role with PCGF5 as part of a PRC1-like complex that mediates monoubiquitination of histone H2A 'Lys-119' on the X chromosome and is required for normal silencing of one copy of the X chromosome in XX females (By similarity)","subcellular_location":"Nucleus; Nucleus, nucleoplasm","url":"https://www.uniprot.org/uniprotkb/Q3KNV8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PCGF3","classification":"Not Classified","n_dependent_lines":21,"n_total_lines":1208,"dependency_fraction":0.0173841059602649},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CSNK2B","stoichiometry":0.2},{"gene":"SNX9","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PCGF3","total_profiled":1310},"omim":[{"mim_id":"617543","title":"POLYCOMB GROUP RING FINGER PROTEIN 3; PCGF3","url":"https://www.omim.org/entry/617543"},{"mim_id":"617407","title":"POLYCOMB GROUP RING FINGER PROTEIN 5; PCGF5","url":"https://www.omim.org/entry/617407"},{"mim_id":"610231","title":"POLYCOMB GROUP RING FINGER PROTEIN 1; PCGF1","url":"https://www.omim.org/entry/610231"},{"mim_id":"300688","title":"BCL6 COREPRESSOR-LIKE 1; BCORL1","url":"https://www.omim.org/entry/300688"},{"mim_id":"300485","title":"BCL6 COREPRESSOR; BCOR","url":"https://www.omim.org/entry/300485"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PCGF3"},"hgnc":{"alias_symbol":["FLJ36550","DONG1","RNF3A","MGC40413"],"prev_symbol":["RNF3"]},"alphafold":{"accession":"Q3KNV8","domains":[{"cath_id":"3.30.40.10","chopping":"8-80","consensus_level":"high","plddt":95.9999,"start":8,"end":80},{"cath_id":"3.10.20.90","chopping":"153-236","consensus_level":"high","plddt":93.7593,"start":153,"end":236}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q3KNV8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q3KNV8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q3KNV8-F1-predicted_aligned_error_v6.png","plddt_mean":85.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PCGF3","jax_strain_url":"https://www.jax.org/strain/search?query=PCGF3"},"sequence":{"accession":"Q3KNV8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q3KNV8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q3KNV8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q3KNV8"}},"corpus_meta":[{"pmid":"29220657","id":"PMC_29220657","title":"hnRNPK Recruits PCGF3/5-PRC1 to the Xist RNA B-Repeat to Establish Polycomb-Mediated Chromosomal Silencing.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29220657","citation_count":264,"is_preprint":false},{"pmid":"28596365","id":"PMC_28596365","title":"PCGF3/5-PRC1 initiates Polycomb recruitment in X chromosome inactivation.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28596365","citation_count":214,"is_preprint":false},{"pmid":"34140779","id":"PMC_34140779","title":"miR-210-3p Promotes Lung Cancer Development and Progression by Modulating USF1 and PCGF3.","date":"2021","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34140779","citation_count":26,"is_preprint":false},{"pmid":"29589913","id":"PMC_29589913","title":"Extratelomeric Binding of the Telomere Binding Protein TRF2 at the PCGF3 Promoter Is G-Quadruplex Motif-Dependent.","date":"2018","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29589913","citation_count":12,"is_preprint":false},{"pmid":"33485844","id":"PMC_33485844","title":"PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the PI3K/AKT signaling pathway.","date":"2021","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33485844","citation_count":11,"is_preprint":false},{"pmid":"32397904","id":"PMC_32397904","title":"PNPT1 and PCGF3 variants associated with angiotensin-converting enzyme inhibitor-induced cough: a nested case-control genome-wide study.","date":"2020","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/32397904","citation_count":5,"is_preprint":false},{"pmid":"39368978","id":"PMC_39368978","title":"Nuclear PCGF3 inhibits the antiviral immune response by suppressing the interferon-stimulated gene.","date":"2024","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/39368978","citation_count":5,"is_preprint":false},{"pmid":"39529637","id":"PMC_39529637","title":"IFN-treated macrophage-derived exosomes prevents HBV-HCC migration and invasion via regulating miR-106b-3p/PCGF3/PI3K/AKT signaling axis.","date":"2024","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/39529637","citation_count":5,"is_preprint":false},{"pmid":"41790891","id":"PMC_41790891","title":"Polycomb repression works without Siesta, the Drosophila ortholog of mammalian PCGF3.","date":"2026","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/41790891","citation_count":0,"is_preprint":false},{"pmid":"41868153","id":"PMC_41868153","title":"Correction: IFN-treated macrophage-derived exosomes prevent HBV-HCC migration and invasion via regulating miR-106b-3p/PCGF3/PI3K/AKT signaling axis.","date":"2026","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/41868153","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.08.07.606990","title":"Canonical and non-canonical PRC1 differentially contribute to the regulation of neural stem cell fate","date":"2024-08-07","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.07.606990","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7046,"output_tokens":2204,"usd":0.027099,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9203,"output_tokens":3175,"usd":0.062695,"stage2_stop_reason":"end_turn"},"total_usd":0.089794,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"PCGF3/5-PRC1 complex initiates Polycomb recruitment during X chromosome inactivation by catalyzing H2AK119 ubiquitylation chromosome-wide, which signals recruitment of other noncanonical PRC1 complexes and PRC2, the latter leading to H3K27 methylation. Pcgf3/5 double knockout results in female-specific embryo lethality and abrogates Xist-mediated gene repression.\",\n      \"method\": \"Genetic knockout (Pcgf3/5 double KO), ChIP-seq, RNA-seq, functional gene silencing assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic epistasis, ChIP-seq, and functional silencing assays across multiple orthogonal methods, replicated in a companion paper\",\n      \"pmids\": [\"28596365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The RNA-binding protein hnRNPK binds the Xist RNA Polycomb Interaction Domain (XR-PID, a ~600 nt sequence encompassing the B-repeat element) and is the principal factor required to recruit PCGF3/5-PRC1 to the inactive X chromosome. Deletion of XR-PID abolishes Polycomb recruitment, gene silencing, and chromatin inaccessibility; synthetic tethering of hnRNPK to Xist RNA lacking XR-PID is sufficient to restore Polycomb recruitment.\",\n      \"method\": \"RNA pulldown, CLIP, deletion mapping of Xist RNA, synthetic tethering of hnRNPK, ATAC-seq, ChIP-seq\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (pulldown, deletion, synthetic tethering, ChIP-seq, ATAC-seq) in a single rigorous study, consistent with companion Science paper\",\n      \"pmids\": [\"29220657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TRF2 (telomere repeat binding factor 2) binds the PCGF3 promoter in a G-quadruplex motif-dependent manner, and this binding requires both the N-terminal and C-terminal domains of TRF2 to mediate PCGF3 promoter activity.\",\n      \"method\": \"G-quadruplex binding assays, promoter-reporter (luciferase) assays, TRF2 domain deletion constructs, chromatin immunoprecipitation\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — promoter-reporter and binding assays in a single lab with two orthogonal methods, but no in vivo functional consequence firmly established\",\n      \"pmids\": [\"29589913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USF1 transcription factor binds the PCGF3 locus and increases its transcription. miR-210-3p targets USF1 and inhibits its expression, thereby reducing PCGF3 levels; PCGF3 knockdown mimics the effects of miR-210-3p overexpression on lung cancer cell proliferation, migration, and invasion in vitro and in vivo.\",\n      \"method\": \"Dual-luciferase reporter assay, RNA immunoprecipitation, siRNA knockdown, xenograft mouse model\",\n      \"journal\": \"OncoTargets and therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — dual-luciferase reporter and RIP provide direct binding evidence; knockdown phenotype confirmed in vivo, but single lab\",\n      \"pmids\": [\"34140779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PCGF3 promotes non-small cell lung cancer cell proliferation and migration by regulating CyclinB1, CyclinD1, and CDK4 expression (proliferation) and RhoA, RhoC, and CDC42 (migration), and these effects are mediated through the PI3K/AKT pathway, as demonstrated by pharmacological inhibition with LY294002.\",\n      \"method\": \"siRNA knockdown, Western blot, cell proliferation and migration assays, PI3K inhibitor (LY294002) rescue experiment\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, downstream pathway placement based on pharmacological inhibition without direct biochemical linkage to PCGF3\",\n      \"pmids\": [\"33485844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Nuclear PCGF3 negatively regulates antiviral immunity by suppressing interferon-stimulated gene (ISG) expression. Upon IFN-I stimulation, PCGF3 is recruited to interferon-stimulated response elements (ISREs) at ISG promoters, where it precludes STAT1 binding and diminishes ISRE activity. PCGF3 deficiency in innate immune cells augments ISG expression.\",\n      \"method\": \"PCGF3 knockdown/knockout in innate immune cells, ChIP assay at ISRE regions, STAT1 binding assays, reporter assays for ISRE activity\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and STAT1 competition assays provide direct mechanistic evidence in a single lab with orthogonal methods\",\n      \"pmids\": [\"39368978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"miR-106b-3p directly targets PCGF3 (validated by dual-luciferase reporter), and PCGF3 knockdown suppresses migration and invasion of HBV-infected HCC cells by reducing p-AKT/AKT and p-PI3K/PI3K signaling.\",\n      \"method\": \"Dual-luciferase reporter assay, siRNA knockdown, Western blot for PI3K/AKT pathway components, scratch/transwell migration assays\",\n      \"journal\": \"Frontiers in Cellular and Infection Microbiology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, direct targeting confirmed by luciferase but PI3K/AKT pathway link is based on downstream protein expression only\",\n      \"pmids\": [\"39529637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In developing mouse neocortex neural stem cells, deletion of Pcgf3/5 (non-canonical PRC1) plays only a minor role in NSC proliferation and differentiation compared to canonical PRC1 (Pcgf2/4 deletion), which strongly reduces proliferation and alters lineage fate.\",\n      \"method\": \"Conditional knockout of Pcgf3/5 vs Pcgf2/4 in neural stem cells, proliferation and differentiation assays, ChIP-seq\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic KO with phenotypic readout and ChIP-seq but preprint, single lab, and the main finding for PCGF3/5 is a minor/negative result\",\n      \"pmids\": [\"bio_10.1101_2024.08.07.606990\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"PCGF3 is a subunit of the noncanonical PCGF3/5-PRC1 complex that initiates Polycomb-mediated X chromosome inactivation by catalyzing H2AK119 ubiquitylation chromosome-wide—a process triggered by hnRNPK binding to the Xist RNA B-repeat/XR-PID element—thereby recruiting other PRC1 complexes and PRC2 to establish H3K27 methylation and gene silencing; additionally, PCGF3 functions in innate immunity by being recruited to ISRE elements to block STAT1 binding and suppress interferon-stimulated gene expression, and its transcription is regulated by TRF2 via a G-quadruplex motif at its promoter and by USF1 downstream of miR-210-3p.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PCGF3 is a subunit of a noncanonical PRC1 complex (PCGF3/5-PRC1) that initiates Polycomb-mediated chromatin silencing, most clearly defined during X chromosome inactivation, where it catalyzes chromosome-wide H2AK119 ubiquitylation that in turn signals recruitment of other noncanonical PRC1 complexes and PRC2 to deposit H3K27 methylation [#0]. Recruitment of PCGF3/5-PRC1 to the inactive X is directed by the RNA-binding protein hnRNPK, which binds the Xist RNA Polycomb Interaction Domain (XR-PID/B-repeat); deleting this element abolishes Polycomb recruitment and silencing, while synthetic tethering of hnRNPK restores it [#1]. Loss of Pcgf3/5 causes female-specific embryonic lethality and abrogates Xist-mediated repression [#0]. Beyond this developmental role, nuclear PCGF3 acts in innate immunity as a negative regulator of antiviral responses: upon type I interferon stimulation it is recruited to interferon-stimulated response elements where it precludes STAT1 binding and dampens interferon-stimulated gene expression [#5]. PCGF3 transcription is controlled at its promoter by TRF2 acting through a G-quadruplex motif [#2] and by USF1, whose activity is constrained by miR-210-3p [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 2017,\n      \"claim\": \"Established that PCGF3 is a functional initiator of Polycomb silencing rather than a passive complex member, by showing PCGF3/5-PRC1 deposits the H2AK119ub mark that nucleates downstream PRC1/PRC2 recruitment during X inactivation.\",\n      \"evidence\": \"Pcgf3/5 double knockout with ChIP-seq, RNA-seq, and functional silencing assays in mouse embryos\",\n      \"pmids\": [\"28596365\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Does not define the catalytic contribution of PCGF3 versus PCGF5 individually\",\n        \"Structure of the PCGF3/5-PRC1 complex and its catalytic mechanism not resolved\",\n        \"Generality of this initiator role beyond X inactivation not established here\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved how PCGF3/5-PRC1 is targeted to chromatin, identifying hnRNPK bound to the Xist XR-PID/B-repeat as the principal recruitment factor and showing tethering of hnRNPK is sufficient to drive Polycomb recruitment.\",\n      \"evidence\": \"RNA pulldown, CLIP, Xist deletion mapping, synthetic hnRNPK tethering, ATAC-seq and ChIP-seq\",\n      \"pmids\": [\"29220657\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct physical contact between hnRNPK and PCGF3 not biochemically mapped\",\n        \"Whether hnRNPK recruits PCGF3/5-PRC1 at non-Xist loci is unknown\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Addressed how PCGF3 expression is set transcriptionally, showing TRF2 binds the PCGF3 promoter via a G-quadruplex motif and requires both its N- and C-terminal domains to drive promoter activity.\",\n      \"evidence\": \"G-quadruplex binding assays, luciferase promoter-reporter assays, TRF2 domain-deletion constructs, ChIP\",\n      \"pmids\": [\"29589913\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No in vivo functional consequence of TRF2-driven PCGF3 expression established\",\n        \"Connection to PCGF3's Polycomb or immune functions not made\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placed PCGF3 in a cancer-relevant regulatory axis, showing USF1 activates PCGF3 transcription and that miR-210-3p represses USF1 to lower PCGF3, with PCGF3 knockdown phenocopying tumor-suppressive effects in lung cancer.\",\n      \"evidence\": \"Dual-luciferase reporter, RNA immunoprecipitation, siRNA knockdown, xenograft model\",\n      \"pmids\": [\"34140779\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which PCGF3 promotes tumor phenotypes not biochemically defined here\",\n        \"Single-lab study\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Proposed a downstream effector pathway for PCGF3 in lung cancer, linking it to cell-cycle and motility regulators via PI3K/AKT signaling.\",\n      \"evidence\": \"siRNA knockdown, Western blot of cyclins/Rho GTPases, migration assays, LY294002 PI3K inhibition\",\n      \"pmids\": [\"33485844\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Pathway placement rests on pharmacological inhibition without direct biochemical link to PCGF3\",\n        \"No demonstration that PCGF3 acts via its Polycomb chromatin function here\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a chromatin-independent-from-XCI role for nuclear PCGF3 in innate immunity, showing it is recruited to ISRE elements where it blocks STAT1 binding to suppress interferon-stimulated genes.\",\n      \"evidence\": \"PCGF3 knockdown/knockout in innate immune cells, ChIP at ISREs, STAT1 binding and ISRE reporter assays\",\n      \"pmids\": [\"39368978\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether ISRE recruitment requires the PCGF3/5-PRC1 complex or H2AK119ub is unknown\",\n        \"Mechanism of PCGF3 recruitment to ISREs not defined\",\n        \"Single-lab study\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended the cancer-axis model to HBV-associated HCC, identifying miR-106b-3p as a direct repressor of PCGF3 with knockdown reducing migration/invasion via PI3K/AKT readouts.\",\n      \"evidence\": \"Dual-luciferase reporter, siRNA knockdown, Western blot for PI3K/AKT, migration/invasion assays\",\n      \"pmids\": [\"39529637\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"PI3K/AKT link based only on downstream protein expression, not direct biochemistry\",\n        \"Single-lab study\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Tested the developmental breadth of PCGF3/5-PRC1, finding it contributes only minimally to neural stem cell proliferation and fate compared with canonical PCGF2/4-PRC1.\",\n      \"evidence\": \"Conditional Pcgf3/5 vs Pcgf2/4 knockout in mouse neocortex NSCs, proliferation/differentiation assays, ChIP-seq (preprint)\",\n      \"pmids\": [\"bio_10.1101_2024.08.07.606990\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Preprint, single lab, and a largely negative result for PCGF3/5\",\n        \"Does not establish whether noncanonical PRC1 has context-specific roles elsewhere in development\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PCGF3's two documented activities—Polycomb H2AK119ub deposition and ISRE-based STAT1 competition—are mechanistically related, and whether its tumor phenotypes derive from either, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No unified model linking chromatin silencing and interferon suppression\",\n        \"No structural characterization of PCGF3 within its complex\",\n        \"Direct substrates and recruitment determinants outside Xist not defined\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [\"PCGF3/5-PRC1\"],\n    \"partners\": [\"PCGF5\", \"HNRNPK\", \"STAT1\", \"TRF2\", \"USF1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}